SELADELPAR GILEAD Hard capsule Ref.[115056] Active ingredients: Seladelpar

Source: European Medicines Agency (EU)  Revision Year: 2025  Publisher: Gilead Sciences Ireland UC, Carrigtohill, County Cork, T45 DP77, Ireland

Product name and form

Seladelpar Gilead 10 mg hard capsules.

Pharmaceutical Form

Hard capsules.

Size 1 (26.1 mm x 9.4 mm) hard capsules with dark blue opaque cap and light grey opaque body imprinted with “CBAY” in white ink on the cap and “10” in black ink on the body.

Qualitative and quantitative composition

Each hard capsule contains seladelpar lysine dihydrate equivalent to 10 mg seladelpar.

For the full list of excipients, see section 6.1.

Active Ingredient

Seladelpar is a peroxisome proliferator-activated receptor delta (PPARδ) agonist, or delpar. PPARδ is a nuclear receptor expressed in the liver and other tissues. PPARδ activation reduces bile acid synthesis in the liver through Fibroblast Growth Factor 21 (FGF21)-dependent downregulation of CYP7A1, the key enzyme for the synthesis of bile acids from cholesterol and by decreasing cholesterol synthesis and absorption. These actions result in lower bile acid exposure in the liver and reduced circulating bile acid levels.

List of Excipients

Capsule contents:

Microcrystalline cellulose
Mannitol
Croscarmellose sodium
Butyl hydroxytoluene
Magnesium stearate
Colloidal silicon dioxide

Capsule shell:

Gelatin
Titanium dioxide
Black iron oxide (E172)
Red iron oxide (E172)
Yellow iron oxide (E172)
Indigo carmine (E132)

Black ink used to imprint “10” (on the body of the capsule shell contains):

Shellac (E904)
Propylene glycol (E1520)
Potassium hydroxide (E525)
Black iron oxide (E172)

White ink used to imprint “CBAY” (on the cap of the capsule contains):

Shellac (E904)
Propylene glycol (E1520)
Sodium hydroxide (E524)
Povidone (E1201)
Titanium dioxide

Pack sizes and marketing

Seladelpar Gilead hard capsules are packaged in a high density polyethylene bottle closed with a polypropylene child resistant cap containing an induction seal. Each bottle contains 30 capsules.

Marketing authorization holder

Gilead Sciences Ireland UC, Carrigtohill, County Cork, T45 DP77, Ireland

Marketing authorization dates and numbers

EU/1/24/1898/001

Date of first authorisation: 20 February 2025

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.